Adherence to glucose-lowering drugs ranges from 41% to 68% depending on drug class.
Brianna Champagne, BSPharm
Advertisement
Articles by Brianna Champagne, BSPharm
High out-of-pocket costs lead patients to skip medications. Financial assistance programs improve adherence, but complex insurance strategies may hinder access.
Long-term benzodiazepine use has been linked to lasting cognitive impairments, underscoring the vital role pharmacists play in supporting safe deprescribing strategies.
Hallucinatory affects associated with psychedelic drugs and Lewy body diseases may have some commonalities.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
2
Kidney Disease Rates Hold Steady for a Decade as Diabetes-Driven Cases Climb
3
Same-Day COVID-19 and Flu Vaccination Does Not Raise Adverse Event Risk, Large VA Study Finds
4
Challenging “Obesity Paradox,” Obesity-Driven Immune Suppression May Increase NSCLC Risk
5